Debates

House Dietary Supplement Listing Act Sparks Debate Over FDA Product Registry

Fri, 08 May 2026 11:56:32 -0400

A new House bill would require dietary supplement manufacturers to register products with FDA, reigniting debate between industry groups over transparency, regulatory burden, and the future of DSHEA oversight.

India’s Ashwagandha Leaf Ban Sparks Debate Over Safety, Science, and Supply Chain

Tue, 05 May 2026 10:35:00 -0400

The Government of India's restriction on ashwagandha leaves in nutritional supplements is sparking industry debate. Experts weigh safety, science, and supply chain impacts of the root-only directive.

Industry Reacts to Dietary Supplement Listing Act of 2026

info@wfcinc.com — Tue, 27 Jan 2026 09:33:39 -0500

AHPA, CRN, and NPA react to the introduction of the Dietary Supplement Listing Act of 2026, renewing a debate within the natural products industry over the role of a mandatory product listing and dietary supplement oversight.

Positioning Plant Protein: What’s the Best Placement?

wfcontribute@wfcinc.com — Fri, 13 Mar 2020 17:13:30 -0400

A flexitarian and an ethical vegan share their thoughts on shelf placement for plant-based foods.

Mandatory Product Listing: Beneficial, or Burdensome?

wfcontribute@wfcinc.com — Wed, 19 Feb 2020 15:58:17 -0500

The FDA has suggested that a mandatory listing requirement for dietary supplements could help ID “bad actors who put the public at risk and undermine consumer confidence in the entire industry." But is it really necessary?

Synthetic Biology: Key to a Healthier Planet—or Threat to Organic?

wfcontribute@wfcinc.com — Thu, 23 Jan 2020 12:00:29 -0500

Experts debate the issue of synthetic biology and GMOs.

Kratom for Chronic Pain?

wfcontribute@wfcinc.com — Thu, 19 Dec 2019 12:00:19 -0500

Fibromyalgia experts discuss Kratom as a pain relief option used under a healthcare provider’s guidance.